The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Holding off until a bit before the holiday is helpful because it takes about 2 weeks for protection to develop after ...
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
The FDA has approved the at-home use of AstraZeneca's FluMist nasal spray vaccine. A prescription will still be required. The vaccines will be available from an on-line pharmacy next fall.
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.
FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...